AI assistant
Sending…
DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2012
Jan 27, 2012
32130_dirs_2012-01-27_68be9910-d146-462d-8333-34d6cc1e6f9e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2012-01-25
Reporting Person: DINA DINO (Director, CEO and Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-01-25 | Common Stock | M | 199998 | $3.00 | Acquired | 495771 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-01-25 | Stock Options | $3.00 | M | 33333 | Disposed | 2012-03-20 | Common Stock (33333) | Direct |
| 2012-01-25 | Stock Options | $3.00 | M | 33333 | Disposed | 2012-03-20 | Common Stock (33333) | Direct |
| 2012-01-25 | Stock Options | $3.00 | M | 66666 | Disposed | 2012-03-20 | Common Stock (66666) | Direct |
| 2012-01-25 | Stock Options | $3.00 | M | 33333 | Disposed | 2012-03-20 | Common Stock (33333) | Direct |
| 2012-01-25 | Stock Options | $3.00 | M | 33333 | Disposed | 2012-03-20 | Common Stock (33333) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 203214 | Indirect |
Footnotes
F1: Represents shares held by Dino Dina 1999 Revocable Trust, of which Dr. Dina is trustee
F2: On January 25, 2012, Dr. Dina exercised all of his then-outstanding options with an expiry date of March 20, 2012 for cash. No shares were sold in the market in connection with this exercise.
More from DYNAVAX TECHNOLOGIES CORP
Director's Dealing
2026
Feb 11
Major Shareholding Notification
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10